Table 1. Characteristics of patients with and without ESA at the start of pre-dialysis care.
all patients | No ESA | ESA | |
Number | 502 | 297 | 205 |
Age | 64.9 (14.3) | 64.4 (14.5) | 65.7 (14.1) |
Sex (% male) | 67.9 | 67.7 | 68.3 |
BMI (kg/m2) | 26.8 (5.2) | 26.6 (5.3) | 27.0 (5.0) |
Primary kidney disease (%) | |||
Diabetes mellitus | 14.3 | 13.5 | 15.6 |
Glomerulonefritis | 13.3 | 12.8 | 14.1 |
Renal vascular disease | 30.7 | 30.3 | 31.2 |
Other | 41.6 | 43.4 | 39.0 |
Comorbidity (%) | |||
Diabetes Mellitus | 26.3 | 24.2 | 29.3 |
Hypertension | 83.2 | 84.8 | 80.9 |
Cardiovascular disease | 41.2 | 43.4 | 38.0 |
eGFR (MDRD) mL/min/1.73 m2 | 16.6 (5.9) | 17.4 (5.8) | 15.6 (6.0) |
Albumin (g/L) | 40.7 (4.6) | 41.0 (4.7) | 40.4 (4.4) |
Hemoglobin (g/dL) | 12.3 (1.5) | 12.4 (1.5) | 12.1 (1.4) |
Values are presented as mean (standard deviation) or percentage.
Abbreviations: ESA = Erythropoiesis-Stimulating Agent, BMI = Body Mass Index, eGFR = estimated Glomerular Filtration Rate.